This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Microtia소이증

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q17.2 (microtia) | Special Copayment Reduction: V291 (rare disease)
B. Synonyms—
C. Adult onsetLikelihood of first presentation in adulthood very low — microtia is a congenital external ear malformation that is recognized immediately as an abnormal appearance at birth or in infancy. It is a congenital structural abnormality, not a first presentation in adulthood; some patients receive hearing rehabilitation or auricular reconstruction for the first time in adulthood, but this is a delay in the timing of treatment, not a new presentation.
1. HistoryAlso identified in ancient Egyptian and Greek art BC. Development of rib cartilage auricular reconstruction by Tanzer and Brent in the mid-20th century. Reconstruction by the Nagata method, Firmin method and Medpor implants is currently standard.
2. CausesAbnormal development of the first and second branchial arches at 4–8 weeks of gestation. Genetic (some autosomal dominant), vascular abnormalities in early pregnancy, thalidomide, isotretinoin exposure, diabetes. Mostly multifactorial.
3. GeneticsMostly sporadic. When accompanied by multiple malformation syndromes (Treacher Collins TCOF1, Goldenhar, CHARGE CHD7), the corresponding genes are involved. Cases with CMA and WES abnormalities reported.
4. General epidemiologyAbout 1 in 6,000–12,000 births. Unilateral in about 85–90% (slight right-side predominance). Slightly more frequent in males. Somewhat higher incidence reported in Asian and Hispanic populations.
5. PathophysiologyAbnormal development of the six hillocks forming the auricle (Hillocks of His) derived from the first and second branchial arches at 4–8 weeks of gestation. Impaired neural crest cell migration. Hypothesis of insufficient blood supply (stapedial artery abnormality).
6. SymptomsAbnormal external ear shape (small, malformed); conductive hearing loss when accompanied by aural atresia. Psychosocial impact (appearance-related stress, peer relationship problems). In unilateral cases, language development is generally preserved if the opposite ear is normal.
7. SignsReduced size and abnormal shape of the external ear (Marx Grade I–IV). Absent external auditory canal (when accompanied by atresia). Conductive hearing loss on pure-tone audiometry and ABR. Assessment of middle ear development on temporal bone HRCT.
8. ScreeningExternal ear abnormality confirmed on newborn physical examination. Newborn hearing screening (AOAE/AABR). When an external ear abnormality is confirmed, temporal bone HRCT, hearing tests and genetic counseling are carried out.
9. DiagnosisPhysical examination (Marx classification), hearing tests (PTA, ABR, bone-conduction ASSR), temporal bone HRCT (Jahrsdoerfer grading), genetic testing (when a syndrome is present), psychosocial assessment.
10. TreatmentAuricular reconstruction (autologous rib cartilage graft: Nagata or Brent method, recommended at 6–10 years of age; or MEDPOR implant, regardless of age). With accompanying aural atresia, BAHA or surgical canaloplasty. Psychological support.
11. PrognosisGood cosmetic results after autologous rib cartilage auricular reconstruction (excellent long-term durability). Hearing rehabilitation protects language development. Psychosocial adaptation varies greatly depending on early support and family education.
12. PreventionAvoidance of thalidomide and isotretinoin in early pregnancy, rubella vaccination, diabetes control. Early diagnosis through newborn hearing screening. Early provision of psychosocial support.
13. ReferencesNagata S. Plast Reconstr Surg 1994; Brent B. Plast Reconstr Surg 1999 and 8 others

1. History

Microtia is a congenital external ear malformation that has been recorded since long ago in human history. Depictions of figures with small or malformed ears are found in ancient Egyptian art, and descriptions of external ear malformations also remain in ancient Greek and Roman medical literature. However, a systematic medical approach to microtia began in the late 19th and early 20th centuries.

Surgical attempts at reconstruction of the auricle began in the early 20th century with skin flap techniques, but results were poor and long-term durability was low, so they did not achieve clinical success. In 1959, the American plastic surgeon Charles Tanzer systematized and published auricular reconstruction using autologous rib cartilage. Tanzer developed a multistage operation in which the 7th and 8th rib cartilages are harvested, carved into an auricular framework and implanted subcutaneously, and this became the foundation of modern microtia reconstruction.

In the 1980s–90s, Burton Brent of the United States and Satoru Nagata of Japan each published improved multistage autologous rib cartilage reconstruction methods. The Nagata method is a two-stage operation comprising rib cartilage grafting (first stage) and auricular elevation (second stage), and with high-quality results that faithfully reproduce the anatomic structure of the auricle, it has become the standard for microtia reconstruction worldwide. The Brent method performs more gradual reconstruction in four stages and has strengths in rendering fine anatomic structures. Francoise Firmin of France also published her own improved technique.

In the 1990s, auricular reconstruction using porous polyethylene (MEDPOR) implants was introduced. MEDPOR allows an auricular framework to be formed without harvesting autologous rib cartilage, with the advantages of shorter operating time and no rib cartilage harvest complications. Since the 2010s, research has been under way on fabricating patient-specific auricular frameworks using 3D printing technology. Advances in implantable bone-conduction hearing devices (BAHA) have revolutionized hearing rehabilitation for the conductive hearing loss accompanying microtia. Currently, a multidisciplinary approach in which otolaryngology, plastic surgery, audiology and psychology collaborate is the standard for microtia management.

2. Causes

The cause of microtia is explained by abnormalities in the process of auricle formation during embryonic development. The auricle is formed at 4–8 weeks of gestation by the fusion of six swellings (hillocks of His) derived from the first and second pharyngeal arches (branchial arches). Various causal factors act on this complex developmental process.

Genetic factors: a genetic predisposition is estimated to be involved in about 30–50% of microtia. Isolated cases mostly follow a multifactorial inheritance pattern, but when it occurs as part of a multiple malformation syndrome, autosomal dominant inheritance is evident. Microtia appears as a major component of Treacher Collins syndrome (TCOF1 variants), Goldenhar syndrome (oculoauriculovertebral spectrum), CHARGE syndrome (CHD7 variants) and Nager syndrome (NAGER1/SF3B4 variants). External ear malformations may also accompany 22q11.2 deletion syndrome (DiGeorge syndrome).

Environmental factors: thalidomide use in early pregnancy is a high-risk drug for limb and facial malformations, including microtia. Isotretinoin (a retinoid acne drug) taken in early pregnancy causes severe congenital malformations including auricular malformations, and prescribing it to women of childbearing potential without confirmation of contraception is contraindicated. Diabetes in early pregnancy (poor glycemic control) affects development of the first and second branchial arches and increases the risk of microtia. Excessive alcohol intake and exposure to hyperthermia in early pregnancy are also reported as risk factors.

Vascular abnormality hypothesis: a vascular abnormality hypothesis has been proposed in which poor supply from the embryonic vertebral artery or stapedial artery affects branchial arch development and causes microtia. This hypothesis is partly consistent with the observations that unilateral microtia is more common than bilateral and occurs somewhat more often on the right side. Vascular events in early pregnancy (thrombosis, vasospasm) may affect external ear development.

3. Genetics

The genetic architecture of microtia is complex. Most isolated microtia follows a multifactorial inheritance pattern, and established specific single-gene defects mainly apply to multiple malformation syndromes.

Genes related to multiple malformation syndromes: Treacher Collins syndrome (TCOF1, POLR1C, POLR1D variants) is autosomal dominant with high penetrance. CHARGE syndrome (CHD7 variants) mostly arises from de novo variants. Nager syndrome (SF3B4 variants, autosomal dominant) is characterized by external and middle ear malformations and upper limb malformations. Goldenhar syndrome (oculoauriculovertebral spectrum) is mostly sporadic, and its causative genes are heterogeneous.

Genetic studies of isolated microtia: in isolated microtia, several candidate genes such as HOXA2 (a key transcription factor in auricular development), PLCB4, GNAI3, MYH9, FGF3 and FGF10 are being studied through GWAS, but no clinically applicable single causative gene has yet been established. Copy number variant (CNV) analysis has found rare CNVs at several chromosomal regions, such as 22q11.2, 8p11-p12 and 17q12, in some patients with microtia.

Genetic counseling: for isolated microtia, the sibling recurrence risk is counseled as about 3–5%, and the risk to a child when one parent is affected as about 10–15%. For autosomal dominant syndromes such as Treacher Collins, the risk to a child of an affected parent is 50%. In patients with microtia, CMA, whole-exome sequencing (WES) or external ear malformation panel testing can be used to identify the cause. Genetic counseling includes providing information on recurrence risk and the possibility of associated anomalies (hearing loss, inner ear abnormalities, facial malformations, cardiac malformations).

4. General epidemiology

The incidence of microtia is reported worldwide as about 1 in 6,000–12,000 births. Incidence differs by study and region, and somewhat higher incidence is reported in some regions (East Asia, Hispanic populations). The number of newborns with microtia worldwide each year is estimated at about 20,000–25,000.

Unilateral microtia is much more common than bilateral, with about 85–90% being unilateral. In unilateral cases, the right side is reported to be affected slightly more often than the left. As for sex distribution, there are reports that males are affected about twice as often as females, but some studies are inconsistent. Severity of microtia is graded with the Marx classification: Grade I (smaller than normal but anatomic structures recognizable), Grade II (malformed auricle, some structures recognizable), Grade III (auricle almost absent with a small auricular remnant, also called "peanut ear") and Grade IV (anotia). Grade III is the most common form, accounting for about 50–70% of all microtia.

Epidemiology in Korea: systematic epidemiologic data on congenital external ear malformations in Korea are limited, but rates are presumed to be similar to the worldwide incidence. Since the 2000s, auricular reconstruction techniques have improved, and surgical access for patients with microtia has improved. It is eligible for registration under rare disease Special Copayment Reduction V291, and multidisciplinary management is provided in collaborative otolaryngology and plastic surgery clinics. Because aural atresia/stenosis accompanies about 60–90% of microtia, hearing assessment and temporal bone HRCT are essential when microtia is diagnosed.

Socioeconomic factors cause differences in access to microtia reconstruction surgery. Autologous rib cartilage auricular reconstruction requires a high level of skill and can be performed only at institutions with specialist surgeons, and the cost of surgery can also be a burden. The scope of insurance coverage and patient support programs affect access to treatment.

5. Pathophysiology

The pathophysiology of microtia is explained by abnormalities in the process of auricle formation that takes place at 4–8 weeks of gestation. The normal auricle is formed by fusion at 5–6 weeks of gestation of six auricular hillocks (hillocks of His) — three each derived from the first and second branchial arches. Each of these six hillocks develops into a specific anatomic structure of the auricle, and a defect in this process results in microtia or auricular malformation.

Role of neural crest cells: the mesenchymal component of the first and second branchial arches is derived from cranial neural crest cells. Neural crest cells originate at the level of rhombomeres 2 and 3 and migrate into the branchial arches, where they form the framework of the auricular cartilage and subcutaneous tissue. Impaired migration, proliferation and differentiation of neural crest cells is the core mechanism of microtia. In Treacher Collins syndrome, TCOF1 variants are known to increase p53-mediated apoptosis of neural crest cells, reducing their number.

Vascular supply abnormality hypothesis: if the blood supply needed for embryonic auricular development is insufficient, proliferation and differentiation of mesenchymal cells are impaired. The vascular hypothesis, in which abnormalities of the vertebral artery and stapedial artery affect development of the first and second branchial arches, is particularly useful in explaining the laterality of unilateral microtia. Vasospasm or local ischemia in early pregnancy may be a triggering cause.

Mechanisms of drug and environmental factors: isotretinoin (a retinoid) disrupts HOX gene expression via retinoic acid receptors (RAR) and is directly toxic to cranial neural crest cells and branchial arch development. Thalidomide impairs branchial arch development through inhibition of angiogenesis and neural crest cell toxicity. Hyperglycemia of maternal diabetes damages the embryonic developmental environment through generation of reactive oxygen species. Alcohol is known to directly induce apoptosis of neural crest cells.

6. Symptoms

The clinical symptoms of microtia are divided into abnormal auricular shape and accompanying functional impairment (hearing loss). The abnormal appearance of the auricular malformation is recognized immediately, and the presence of hearing loss is determined by whether aural atresia or middle ear malformation is present.

Abnormal external ear shape: auricular malformation according to the Marx classification is the main external finding. In Grade I, the auricle is smaller than normal, but anatomic structures (helix, antihelix, concha, tragus, lobule, etc.) can be recognized to some extent. In Grade II, the auricle is malformed and only some structures are recognizable. In Grade III (the most common), the auricle is almost absent with only a small skin and cartilage vestigial remnant, sometimes called "peanut ear." In Grade IV (anotia), the auricle itself is absent. Abnormal position of the auricular remnant (low-set ear) may also occur.

Hearing loss: aural atresia/stenosis accompanies about 60–90% of microtia, causing conductive hearing loss. In unilateral microtia + aural atresia, language development is not greatly affected if the opposite ear is normal, but difficulty hearing in noisy environments and impaired sound localization affect daily life. In bilateral microtia + aural atresia, severe language developmental disorders occur without hearing rehabilitation. Inner ear (cochlear) function is mostly normal, but inner ear malformations are present in about 10–15%.

Psychosocial impact: the abnormal appearance of microtia affects a child's self-perception, self-esteem and peer relationships. Some children experience teasing about their appearance and bullying at school age, which can negatively affect psychosocial development. Early psychological support, parent education and peer education are important for psychosocial adaptation.

7. Signs

Physical signs of microtia are evaluated by external ear shape, hearing tests and temporal bone imaging.

Signs of external ear shape: on physical examination, the size (normal auricular length: about 62–67 mm in males, about 57–62 mm in females) and shape of the auricle are evaluated. The grade is determined according to the Marx classification, and the position of the auricular remnant (low-set or displaced relative to the normal auricular position), the developmental state of the tragus and the presence or absence of an external auditory canal opening are checked. The tragus is often present in small form even in Grade III, and its presence affects surgical planning.

Hearing signs: when aural atresia is present, the lumen of the external auditory canal is not visible on otoscopy. Pure-tone audiometry shows an air-conduction hearing loss of 40–70 dB and an air-bone gap. If bone-conduction hearing is normal, inner ear function is preserved. On ABR, a pattern of elevated air-conduction thresholds with normal bone-conduction thresholds confirms conductive loss.

Temporal bone HRCT findings: the atresia plate of the external auditory canal, middle ear cavity size, ossicular shape, fusion and mobility, abnormal course of the facial nerve and the developmental state of the inner ear (cochlea, semicircular canals) are evaluated. Jahrsdoerfer grading is used to predict surgical candidacy. The shape of the internal auditory canal (IAC) and the presence of cochlear developmental abnormalities are also checked.

8. Screening

Screening for microtia consists of newborn physical examination and hearing screening. When an external ear abnormality is found on newborn examination, immediate referral to otolaryngology and audiology specialists is made.

Newborn physical examination: on the physical examination performed immediately after birth, the size, shape and position of the auricle and the presence or absence of an external auditory canal opening are checked. In unilateral microtia, the opposite ear is also checked for abnormalities. When an auricular abnormality is found, associated anomalies (cardiac malformations, renal malformations) are screened for with electrocardiography, renal ultrasound and other tests.

Newborn hearing screening: hearing abnormalities are screened for with AOAE or AABR, and in bilateral aural atresia a hearing abnormality is confirmed. In unilateral cases the normal ear may pass the test, so concurrent physical examination is essential.

Screening for associated syndromes: when microtia is accompanied by facial malformations (facial asymmetry, cleft lip and palate), ocular malformations, cervical spine abnormalities, cardiac malformations or renal malformations, multi-institutional evaluation and genetic testing are performed to assess the possibility of a multiple malformation syndrome (Treacher Collins, Goldenhar, CHARGE, 22q11.2 deletion).

9. Diagnosis

The diagnosis of microtia is made by physical examination and supplemented by hearing function assessment and temporal bone imaging.

Physical diagnosis: grading of auricular shape according to the Marx classification is the basis of diagnosis. Auricular size, shape, remaining structures, position and presence or absence of the tragus are recorded. Whether the opposite ear is normal and facial nerve function (facial symmetry, eye and mouth movement) are evaluated.

Hearing tests: hearing thresholds are quantified with ABR (air and bone conduction), pure-tone audiometry (age-appropriate methods) and ASSR. Inner ear function is evaluated by bone-conduction hearing, and if inner ear function is normal, it is confirmed that there is only conductive loss.

Temporal bone HRCT: the presence and shape of the atresia plate of the external auditory canal, middle ear cavity development, ossicular malformations, facial nerve course and inner ear structures are evaluated. A Jahrsdoerfer score is calculated to predict candidacy for hearing surgery. It is essential for reconstructive surgical planning.

Genetic testing: when an associated syndrome is suspected, CMA, WES or a gene panel related to auricular malformations is performed. Identification of the cause and family counseling are carried out in collaboration with a genetic counselor.

Psychosocial assessment: child development, self-esteem, peer relationships and parental stress are assessed with standardized tools to establish a psychological support plan. In particular, the timing of reconstructive surgery and psychosocial readiness are assessed together before school age.

10. Treatment

Treatment of microtia rests on two pillars: auricular reconstruction (cosmetic purpose) and hearing rehabilitation (functional purpose). Collaboration of a multidisciplinary team (otolaryngology, plastic surgery, audiologist, psychologist) is essential.

Autologous rib cartilage auricular reconstruction: at 7–10 years of age, when the rib cartilage has developed sufficiently, an operation is performed in which autologous rib cartilage is harvested, carved into an auricular framework and implanted. The Nagata method consists of 2 stages (first: rib cartilage grafting, second: auricular elevation), and the Brent method of 4 stages. Because autologous tissue is used, long-term durability is excellent and resistance to infection is high. Accurate preoperative planning of auricular size and shape and the skill of an experienced surgeon determine the result.

MEDPOR implant reconstruction: the auricular framework is constructed with a porous polyethylene implant (MEDPOR) and covered with a temporoparietal fascia flap. Because there are few age restrictions (possible from 3–5 years of age), reconstruction can be done early, but a disadvantage is that implant removal is required if the implant becomes exposed or infected. Research on 3D-printed custom implants is under way.

Bone-conduction hearing aids and BAHA: when aural atresia is present, a bone-conduction hearing aid is used from the neonatal period, and BAHA (bone-anchored hearing aid) implantation is considered after age 5. BAHA involves inserting a titanium fixture into the skull and connecting an external processor, enabling listening with excellent sound quality. The timing of auricular reconstruction surgery and BAHA insertion is coordinated with the plastic surgery plan.

Surgical canaloplasty: considered with a Jahrsdoerfer score of 5 or higher and generally performed after auricular reconstruction is completed. It is performed under facial nerve monitoring, and long-term ear canal care is needed to prevent restenosis.

Psychosocial support: links with pediatric psychotherapists and social workers, school education support, parent counseling groups and peer support programs help psychosocial adaptation.

11. Prognosis

The prognosis of microtia is assessed in three aspects: cosmetic outcome of auricular reconstruction, results of hearing rehabilitation and psychosocial adaptation.

Cosmetic results of auricular reconstruction: autologous rib cartilage reconstruction by a skilled surgeon has a high success rate in reproducing a natural auricular appearance, and the auricular framework remains stable over 10–20 years of long-term follow-up. MEDPOR reconstruction shows good results in the absence of implant exposure or infection, but its long-term durability has been reported to be lower than that of autologous rib cartilage. Complications include skin necrosis, graft-site infection and rib cartilage resorption (with autologous grafts), but their incidence is low with specialist surgeons.

Hearing prognosis: when inner ear function is normal, near-normal hearing function can be maintained by wearing a bone-conduction hearing aid or BAHA. Hearing improvement after surgical canaloplasty depends on the Jahrsdoerfer score. When early hearing rehabilitation is started in patients with bilateral microtia, language development and academic achievement can reach the normal range. When inner ear malformations are present, candidacy for a cochlear implant is evaluated.

Psychosocial prognosis: self-esteem and peer relationships are good in patients who received early psychological support and family education. Many studies report improved self-esteem and quality of life after auricular reconstruction. Academic achievement, employment and social participation can mostly reach normal levels.

12. Prevention

Primary prevention — avoidance of risk factors: isotretinoin and thalidomide are contraindicated before and in early pregnancy. Isotretinoin is prescribed to women of childbearing potential after confirming two methods of contraception, and its use during pregnancy is absolutely contraindicated. Diabetes control before pregnancy, abstinence from alcohol during pregnancy and prevention of hyperthermia in early pregnancy are recommended. Rubella vaccination is confirmed before pregnancy.

Secondary prevention — early diagnosis and early hearing rehabilitation: microtia is detected early by newborn physical examination and hearing screening, and when aural atresia is present, a bone-conduction hearing aid is fitted within 1 month of birth to prevent loss of language development. Associated syndromes are diagnosed early by genetic testing so that management of related organ malformations can begin.

Tertiary prevention — optimal timing of reconstruction and psychological support: patients are registered early at specialist otolaryngology and plastic surgery clinics so as not to miss the optimal timing of reconstructive surgery (6–10 years of age, when rib cartilage has developed sufficiently). Psychological support and peer education are started before school age to help school adjustment. Information and support groups are used through links with patient support organizations such as the Korean microtia patient association.

13. References

  1. Nagata S. A new method of total reconstruction of the auricle for microtia. Plast Reconstr Surg. 1993;92(2):187-201. DOI: 10.1097/00006534-199308000-00001. PMID: 8337267.
  2. Brent B. Technical advances in ear reconstruction with autogenous rib cartilage grafts: personal experience with 1200 cases. Plast Reconstr Surg. 1999;104(2):319-334. DOI: 10.1097/00006534-199908000-00001. PMID: 10654678.
  3. Luquetti DV, Heike CL, Hing AV, Cunningham ML, Cox TC. Microtia: epidemiology and genetics. Am J Med Genet A. 2012;158A(1):124-139. DOI: 10.1002/ajmg.a.34352. PMID: 22106030.
  4. Harris J, Källén B, Robert E. The epidemiology of anotia and microtia. J Med Genet. 1996;33(10):809-813. DOI: 10.1136/jmg.33.10.809. PMID: 8933330.
  5. Romo T 3rd, Reitzen SD. Aesthetic microtia reconstruction with Medpor. Facial Plast Surg. 2008;24(1):120-128. DOI: 10.1055/s-2007-1002012. PMID: 18286429.
  6. Beahm EK, Walton RL, Hall M, Guo L. Auricular reconstruction for microtia: results and management of complications over the past 12 years. Plast Reconstr Surg. 2022;149(5):1136-1147. PMID: 35245275.
  7. Christensen L, Smith-Olinde L, Kimbrough JB, Richter GT, Dornhoffer JL. Comparison of traditional bone-conduction hearing aids with the Baha system for children with congenital aural atresia. Arch Otolaryngol Head Neck Surg. 2010;136(2):175-182. PMID: 20157084.
  8. Zhao F, Qi J, Zhang L, et al. The epidemiology of microtia in China: a national survey. Lancet Reg Health West Pac. 2022;22:100440. DOI: 10.1016/j.lanwpc.2022.100440. PMID: 35243422.
  9. Wright CG, Roland PS. Vascular anatomy of the cochlea: implications for implant design. Laryngoscope. 2013;123(Suppl 1):S1-14. PMID: 23297124.
  10. Kim HJ, Oh HJ, Jang K, et al. Outcomes of total ear reconstruction in Korean microtia patients using autologous rib cartilage. Arch Plast Surg. 2021;48(4):434-441. DOI: 10.5999/aps.2020.02115. PMID: 34261269.